Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
538.92
+2.14 (0.40%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.86B in the quarter ending June 28, 2025, with 2.98% growth. This brings the company's revenue in the last twelve months to $43.21B, up 2.05% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.21B
Revenue Growth
+2.05%
P/S Ratio
4.74
Revenue / Employee
$345,696
Employees
125,000
Market Cap
203.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TMO News
- 3 days ago - Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI - Business Wire
- 3 days ago - Thermo Fisher Scientific Fuels the Future of Multi-omics Research with the Launch of Next-Generation Microarray Solution - Business Wire
- 11 days ago - Thermo Fisher Scientific Introduces New Molecular Microscope® Diagnostic System to Aid in Evaluation of Lung Transplant Rejection - Business Wire
- 17 days ago - Top 15 High-Growth Dividend Stocks For October 2025 - Seeking Alpha
- 18 days ago - Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub - Business Wire
- 18 days ago - Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025 - Business Wire
- 18 days ago - Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - Business Wire
- 18 days ago - Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal - Benzinga